This Article  • References  • Full text PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Stuart L. Fine, MD

Arch Ophthalmol. 1993;111(9):1186-1188.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SINCE AGE-RELATED macular degeneration (AMD) is the most frequent cause of severe vision loss in the Western Hemisphere, it is likely that all ophthalmologists will examine increasing numbers of patients with AMD as the population ages. Unlike the patient with cataract for whom treatment usually improves vision and the patient with diabetic retinopathy for whom treatment usually stabilizes vision, the majority of patients with the neovascular form of AMD cannot expect their vision to improve or stabilize with or without treatment.^1,2 Nevertheless, ophthalmologists can provide an accurate description of the condition, reasonably precise prognostic information, access to low vision rehabilitation services, and a great deal of compassion. Occasionally, we can offer treatment. What follows is my approach to counseling a patient who presents with monocular loss of vision from the neovascular complications of AMD.

I begin by confirming the diagnosis to the patient and family members. I emphasize that . . . [Full Text PDF of this Article]

Author Affiliations
Philadelphia, Pa

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?